Skip to main content
. 2014 Nov 21;4(6):454–463. doi: 10.1016/j.apsb.2014.10.005

Table 1.

Composition of various batches of HP-SLNs.

Formulation Variable
Drug (mg) Lipid (mg) Surfactant (% w/v) Stirring speed (rpm) Stirring time (h)
OH1 50 100 1.5 3000 2
OH2 43.75 87.5 1.5 3000 2
OH3 43.75 87.5 1.625 3000 2
OH4 50 100 1.625 3000 2
OPH 50 100 1.625 3000 2.5